Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Operating Income: 2021-2025

Historic Operating Income for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -$57.4 million.

  • Core Scientific's Operating Income fell 39.32% to -$57.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$166.1 million, marking a year-over-year decrease of 777.33%. This contributed to the annual value of -$19.2 million for FY2024, which is 314.22% down from last year.
  • Core Scientific's Operating Income amounted to -$57.4 million in Q3 2025, which was down 118.48% from -$26.3 million recorded in Q2 2025.
  • Core Scientific's Operating Income's 5-year high stood at $102.2 million during Q4 2021, with a 5-year trough of -$1.0 billion in Q2 2022.
  • For the 3-year period, Core Scientific's Operating Income averaged around -$12.4 million, with its median value being -$12.0 million (2023).
  • In the last 5 years, Core Scientific's Operating Income plummeted by 8,489.92% in 2022 and then skyrocketed by 626.48% in 2024.
  • Quarterly analysis of 5 years shows Core Scientific's Operating Income stood at $102.2 million in 2021, then crashed by 722.64% to -$636.1 million in 2022, then skyrocketed by 100.62% to $3.9 million in 2023, then crashed by 1,111.26% to -$39.8 million in 2024, then slumped by 39.32% to -$57.4 million in 2025.
  • Its Operating Income was -$57.4 million in Q3 2025, compared to -$26.3 million in Q2 2025 and -$42.6 million in Q1 2025.